Soluble ST2 and CXCL-10 may serve as biomarkers of subclinical diastolic dysfunction in SLE and correlate with disease activity and damage.
Ehud ChorinAviram HochstadtUri AradEihab GhantousSmadar GertelDavid LevartovskyIrena LitinskyOfir ElaluofAri PolachekIlana KaufmanValerie AloushSara BorokIrena WiglerJonathan WollmanDan CaspiMichal Laufer-PerlSevan Letourneau-ShesafShlomo BerlinerOri ElkayamYan TopilskyDaphna ParanPublished in: Lupus (2020)
Soluble ST2 and CXCL-10 are markers of disease activity and accrued damage in SLE and may serve as sensitive biomarkers for detection of subclinical diastolic dysfunction, independent of traditional cardiovascular risk factors.
Keyphrases
- disease activity
- cardiovascular risk factors
- systemic lupus erythematosus
- oxidative stress
- rheumatoid arthritis
- rheumatoid arthritis patients
- left ventricular
- ankylosing spondylitis
- blood pressure
- juvenile idiopathic arthritis
- cardiovascular disease
- metabolic syndrome
- ejection fraction
- heart failure
- loop mediated isothermal amplification
- label free